Matthew Wright - Genentech, Inc. | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 90 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

ASO Visual Abstract: Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using the Codman Vascular Catheter with the Medtronic Synchromed II Pump for Intrahepatic Cancers

Hannah G. McDonald, Omar A. Zaki,Matt J. Wright,Rani Jayswal,Heidi Weiss,Rashmi T. Nair,Halemane Ganesh, Scott Ellis,Jill M. Kolesar,Jessica Moss,Mautin Barry-Hundeyin,Prakash K. Pandalai,Joseph Kim,Reema A. Patel,Michael J. Cavnar

ANNALS OF SURGICAL ONCOLOGY（2024）

引用0浏览0WOS引用

Retrospective Assessment of Translational Pharmacokinetic–Pharmacodynamic Modeling Performance: A Case Study with Apitolisib, a Dual PI3K/mTOR Inhibitor

Anita Moein,Jin Y. Jin,Matthew R. Wright,Bruno Alicke,Harvey Wong

DRUGS IN R&Dno. 2 (2024): 155-167

引用0浏览0WOS引用

Quantitative Assessment of Drug Efficacy and Emergence of Resistance in Patients with Metastatic Renal Cell Carcinoma Using a Longitudinal Exposure-Tumor Growth Inhibition Model: Apitolisib (dual PI3K/mTORC1/2 Inhibitor) Versus Everolimus (mtorc1 Inhibitor)

Anita Moein,Jin Y. Jin,Matthew R. Wright,Harvey Wong

JOURNAL OF CLINICAL PHARMACOLOGYno. 9 (2024): 1101-1111

引用0浏览0WOS引用

Quantitative Characterization of the Effects of Fulvestrant Alone or in Combination with Taselisib (pi3kinase Inhibitor) on Longitudinal Tumor Growth in Patients with Estrogen Receptor-Positive, HER2-negative, PIK3CA-mutant, Advanced or Metastatic Breast Cancer

Anita Moein,Jin Y. Jin,Matthew R. Wright,Harvey Wong

Cancer Chemotherapy and Pharmacologypp.1-16, (2024)

引用0浏览0WOS引用

CryoEM Reveals Unprecedented Binding Site for NaV1.7 Inhibitors Enabling Rational Design of Potent Hybrid Inhibitors

Marc Kschonsak,Christine C. Jao,Christopher P. Arthur,Alexis L. Rohou,Philippe Bergeron,Daniel F. Ortwine,Steven J. McKerrall,David H. Hackos,Lunbin Deng,Jun Chen,Tianbo Li,Peter S. Dragovich,Matthew Volgraf,Matthew R. Wright,Jian Payandeh,Claudio Ciferri,John C. Tellis

ELIFE (2023)

引用1浏览0引用

Filling a Nick in NIK: Extending the Half-Life of a NIK Inhibitor Through Structure-Based Drug Design

Bioorganic & Medicinal Chemistry Letters (2023): 129277

引用1浏览0WOS引用

New Methodology for Determining Plasma Protein Binding Kinetics Using an Enzyme Reporter Assay Coupling with High-Resolution Mass Spectrometry

Zhengyin Yan,Li Ma,Julie Huang,Pasquale Carione,Jane R. Kenny,Cornelis E. C. A. Hop,Matthew Wright

Analytical chemistry（2023）

引用2浏览0WOS引用

Clinical Experience with a Power Injectable Arm Port

Matthew Wright,Navraj Dhaliwal, Ho Le,Brent Burbridge

Journal of the Association for Vascular Access (2022)

引用0浏览0引用

Physiologically Based Pharmacokinetic Models Can Be Used to Predict the Unique Nonlinear Absorption Profiles of Vismodegib

Louis Lin,Matthew R. Wright,Cornelis E. C. A. Hop,Harvey Wong

Drug Metabolism and Disposition（2022）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn